Evidence map›Paper›PMID 34312305›Full record

ArticleeNeuro

Maternal Oxycodone Treatment Results in Neurobehavioral Disruptions in Mice Offspring.

Rachel E Martin, Madison T Green, Jessica A Kinkade, Robert R Schmidt, Tess E Willemse, A Katrin Schenk, Jiude Mao, Cheryl S Rosenfeld

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Effects of oxycodone on placental lineages: Evidence from the transcriptome profile of mouse trophoblast giant cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. The placenta as a target of opioid drugs†.Biology of reproduction · 2022
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rachel E MartinChristopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211.
Madison T GreenChristopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211.
Jessica A KinkadeChristopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211.
Robert R SchmidtChristopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211.
Tess E WillemseChristopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211.
A Katrin SchenkPhysics, Randolph College, Lynchburg, VA 24503.
Jiude MaoChristopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211.
Cheryl S RosenfeldChristopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211 rosenfeldc@missouri.edu.ORCID 0000-0002-4137-3933
University of Missouri · USRandolph College · USUniversity of Missouri Health System · US

Funding

Endocrine Disrupting Chemicals, Epigenetic Alterations, and Autism-Like Behaviors in the Highly Social California Mouse ModelR01ES025547 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROBERTS, R. MICHAEL · 2016 to 2020
$1.9M
NIEHS NIH HHS R01 ES025547
6 · The paper itself

Abstract

Opioid drugs are increasingly being prescribed to pregnant women. Such compounds can also bind and activate opioid receptors in the fetal brain, which could lead to long-term brain and behavioral disruptions. We hypothesized that maternal treatment with oxycodone (OXY), the primary opioid at the center of the current crisis, leads to later neurobehavioral disorders and gene expression changes in the hypothalamus and hippocampus of resulting offspring. Female mice were treated daily with 5 mg OXY/kg or saline solution (control; CTL) for two weeks before breeding and then throughout gestation. Male and female offspring from both groups were tested with a battery of behavioral and metabolic tests to measure cognition, exploratory-like, anxiety-like, voluntary physical activity, and socio-communication behaviors. qPCR analyses were performed for candidate gene expression patterns in the hypothalamus and hippocampus of OXY and CTL derived offspring. Developmental exposure to OXY caused socio-communication changes that persisted from weaning through adulthood. Such offspring also showed cognitive impairments, reduced voluntary physical activity, and weighed more than CTL counterparts. In the hippocampus, prenatal exposure to OXY caused sex-dependent differences in expression of genes encoding opioid receptors and those involved in serotonin signaling. OXY exposure induced changes in neuropeptide hormone expression and the epigenetic modulator,

Indexed as

OxycodonePrenatal Exposure Delayed EffectsAnimalsAnxietyEpigenesis, GeneticFemaleHippocampusHypothalamusMaleMicePregnancyOxycodoneanalgesicbrainDOHaDdrug abusegene expressionopioid

Identifiers

PMID34312305
PMCPMC8354714
OpenAlexW3183986501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.